Targeting tryptophan hydroxylase 2 in affective disorder

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 11, 2010, Pages 1259-1271

  Popova, Nina K ^a   Kulikov, Alexander V ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Affective disorders; Polymorphism; Sensitivity to psychotropic drugs; Tryptophan hydroxylase 2

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 2;

AMINO ACID METABOLISM; ANIMAL BEHAVIOR; BEHAVIOR CHANGE; BEHAVIOR CONTROL; DEPRESSION; DIETARY INTAKE; DNA POLYMORPHISM; DRUG RESPONSE; DRUG TARGETING; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MOOD DISORDER; NONHUMAN; PHARMACOGENETICS; PROTEIN TARGETING; PSYCHOPHARMACOTHERAPY; REVIEW; SEROTONIN RELEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG DESIGN; DRUG RESISTANCE; ENZYME INHIBITORS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOOD DISORDERS; POLYMORPHISM, GENETIC; PSYCHOTROPIC DRUGS; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE;

EID: 77958054867     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.2010.524208     Document Type: Review

References (149)

1. Lucki I. The spectrum of behavior influenced by serotonin. Biol Psychiatry 1998;44:151-162
2. Popova NK. From genes to aggressive behavior: the role of serotonergic system. Bioessays 2006;28:495-503
3. Markus CR. Dietary amino acids and brain serotonin function; implications for stress-related affective changes. Neuromol Med 2008;10:247-258
4. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom EE, Kupfer NN, editors, Psychopharmacology. The fourth generation of progress. Raven Press, New York; 1995. p. 933-944
5. Van Praag HM. Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 2004;28:891-907
6. Moore P, Landolt H-P, Seifritz E, et al. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 2000;23:601-622
7. Wilk S. Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in psychiatric disorders: a critical assessment. In: Barchas J, Usdin E, editors, Serotonin and behavior. Academic Press, New York; 1973. p. 483-486
8. Lloyd KG, Farley IJ, Deck JH, Hornykiewicz O. Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Biochem Psychopharmacol 1974;11:387-397
9. Van Praag HM. Towards a biochemical classification of depression. Adv Biochem Psychopharmacol 1974;11:357-368
10. Brown GL, Goodwin FK, Bunney WE. Human aggression and suicide: their relationship to neuropsychiatric diagnoses and serotonin metabolism. Adv Biochem Psychopharmacol 1982;34:287-307
11. Banki CM, Arato M, Papp S, Kurcz M. Cerebrospinal fluid 5HIAA and tryptophan in depression and suicide. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H, editors, Progress in tryptophan and serotonin research, Berlin Walter de Gruyter; 1984. p. 397-400
12. Albert VR, Allen JM, Joh TH. A single gene codes for aromatic L-amino acid decarboxylase in both neuronal and non neuronal tissues. J Biol Chem 1987;262:9404-9411
13. Fitzpatrick PF. Tetrahydopterin-dependent amino acid hydroxylases. Annu Rev Biochem 1999;68:355-381
14. Fitzpatrick PF. Mechanism of aromatic amino acid hydroxylation. Biochemistry 2003;42:14083-14091
15. Darmon MC, Guibert B, Leviel V, et al. Sequence of two mRNAs encoding active rat tryptophan hydroxylase. J Neurochem 1988;51:312-316
16. Stoll J, Kozak CA, Goldman D. Characterization and chromosomal mapping of a cDNA encoding TPH from a mouse mastocytoma cell line. Genomics 1990;7:88-96
17. Boularand S, Darmon MC, Ganem Y, et al. Complete coding sequence of human TPH. Nucleic Acid Res 1990;18:42-57
18. Walther DJ, Peter J-U, Bashammakh S, et al. Synthesis of serotonin by a second thryptophan hydroxylase isoform. Science 2003;299:76
19. Walther D, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003;66:1673-1680
20. Zhang X, Beaulieu J-M, Gainetdinov RR, Caron MG. Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cell Mol Life Sci 2006;63:6-11
21. Popova NK, Konusova AV. Brain and peripheral effects of serotonin on thermoregulation. Biogenic Amines 1985;3:125-134
22. Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 1966;154:499-516
23. Mehta H, Saravanan KS, Mohanakumar KP. Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice. Behav Brain Res 2003;145:31-36
24. Dailly E, Chenu F, Petit-Demoulière B, Bourin M. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins. J Neurosci Methods 2006;150:111-115
25. Kornum BR, Licht CL, Weikop P, et al. Central serotonin depletion affects rat brain areas differently: a qualitative and quantitative comparison between different treatment schemes. Neurosci Lett 2006;392:129-134
26. Gutknecht L, Waider J, Kraft S, et al. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm 2008;115:1127-1132
27. Savelieva KV, Zhao S, Pogorelov VM, et al. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS ONE 2008;3:e3301
28. Alenina N, Kikic D, Todiras M, et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci USA 2009;106:10333-10337
29. Zill P, Buttner A, Eisenmenger W, et al. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J Psychiatr Res 2007;41:168-173
30. Perroud N, Neidhart E, Petit B, et al. Simultaneous analysis of serotonin transporter, thryptophan hydroxylase 1 and 2 gene expression in the ventral prefrontal cortex of suicide victims. Am J Med Genet B 2010;153B:909-918
31. Nakamura K, Hasegawa H. Developmental role of tryptophan hydroxylase in the nervous system. Mol Neurobiol 2007;35:45-54
32. Abumaria N, Ribic A, Anacker C, et al. Stress upregulates TPH1 but not TPH2 mRNA in the rat dorsal raphe nucleus: identification of two TPH2 mRNA splice variants. Cell Mol Neurobiol 2008;28:331-342
33. Porsolt R, Anton G, Blavett N, Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-391
34. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-732
35. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacol 1988;94:147-160
36. Willner P. Animal models of depression: an overview. Pharmacol Ther 1990;45:425-455
37. Willner P, Mitchell PJ. The validity of animal models of predisposition to depression. Behav Pharmacol 2002;13:169-188
38. Beaulieu J-M, Zhang X, Rodriguiz RM, et al. Role of GSK3beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 2008;105:1333-1338
39. Zhang X, Beaulieu J-M, Sotnikova TD, et al. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004;305:217
40. Sakowski SA, Geddes TJ, Kuhn DM. Mouse tryptophan hydroxylase isoform 2 and the role of proline 447 in enzyme function. J Neurochem 2006;96:758-765
41. Kulikov AV, Osipova DV, Naumenko VS, Popova NK. Association between Tph2 gene polymorphism, brain tryptophan hydroxylase activity and aggressiveness in mouse strains. Genes Brain Behav 2005;4:482-485
42. Kulikov AV, Osipova DV, Popova NK. The C1473G polymorphism in gene tph2 is the main factor mediating the genetically defined variability of tryptophan hydroxylase-2 activity in the mouse brain. Russ J Genet 2007;43:1408-1412
43. Osipova DV, Kulikov AV, Popova NK. C1473G polymorphism in mouse tph2 gene is linked to tryptophan hydroxylase-2 activity in the brain, intermale aggression, and depressive-like behavior in the forced swim test. J Neurosci Res 2009;87:1168-1174
44. Siesser WB, Zhang X, Jacobsen JPR, et al. Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6J and BALB/cJ congenic mice. Neurosci Lett 2010;481:6-11
45. Tenner K, Qadri F, Bert B, et al. The mTPH2 C1473G single nucleotide polymorphism is not responsible for behavioural differences between mouse strains. Neurosci Lett 2008;431:21-25
46. Kulikov AV, Popova NK. Association between intermale aggression and genetically defined tryptophan hydroxylase activity in the mouse brain. Aggr Behav 1996;22:111-117
47. Osipova DV, Kulikov AV, Mekada K, et al. Distribution of the C1473G polymorphism in tryptophan hydroxylase 2 gene in laboratory and wild mice. Genes Brain Behav 2010;9:537-543
48. Popova NK, Kulikov AV, Nikulina EM, et al. Serotonin metabolism and serotonergic receptors in Norway rats selected for low aggressiveness to man. Aggr Behav 1991;17:207-213
49. Popova NK, Voitenko NN, Kulikov AV, Avgustinovich DF. Evidence for the involvement of central serotonin in mechanism of domestication of silver foxes. Pharmacol Biochem Behav 1991;40:751-756
50. Popova NK. Brain serotonin in genetically defined defensive behavior. In: Millar R, Ivanitsky AM, Balaban PM, editors, Complex brain functions: conceptual advances in Russian neuroscience. Harwood Press, New York; 1999. p. 307-329
51. Dixon AK. Ethological strategies for defense in animals and humans: their role in some psychiatric disorders. Br J Med Psychol 1998;71:417-445
52. Sanberg PR, Bunsey MD, Giordano M, Norman AB. The catalepsy test: its ups and downs. Behav Neurosci 1988;102:748-759
53. Popova N, Kulikov A. On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models. Am J Med Genet (Neuropsychiatric Genetics) 1995;60:214-220
54. Kulikov A, Kozlachkova E, Kudryavtseva N, Popova N. Correlation between tryptophan hydroxylase activity in the brain and predisposition to pinch-induced catalepsy in mice. Pharmacol Biochem Behav 1995;50:431-435
55. Kulikov A, Kozlachkova E, Popova N. The activity of tryptophan hydroxylase in brain of hereditary predisposed to catalepsy rats. Pharmacol Biochem Behav 1992;43:999-1003
56. Kulikov AV, Kolpakov VG, Popova NK. The genetic cataleptic (GC) rat strain as a model of depressive disorders. In: Kaluev A, editor, Animal models in biological psychiatry. Nova Science Publishers, New York; 2006. p. 59-73
57. Kulikov AV, Popova NK. Genetic control of catalepsy in mice. In: Torres S, Martin M, editors, Genetic predisposition to disease. Nova Publishers, New York; 2008. p. 215-236
58. De Luca V, Likhodi O, Van Tol HH, et al. Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacol 2005;183:378-382
59. Bach-Mizrachi H, Underwood MD, Kassir SA, et al. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacol 2006;31:814-824
60. Bach-Mizrachi H, Underwood MD, Tin A, et al. Evaluated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressive suicides. Mol Psychiatry 2008;13:507-513
61. Bonkale WL, Turecki G, Austin MC. Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressive suicide subjects is restricted to the dorsal subnucleus. Synapse 2006;60:81-85
62. De Luca V, Likhodi O, Van Tol HH, et al. Gene expression of tryptophan hydroxylase 2 in post-mortem brain of suicide subjects. Int J Neuropsychopharmacol 2006;9:21-25
63. Shamir A, Shaltiel G, Levi I, et al. Postmortem pariantal cortex TPH2 expression is not altered in schizophrenic, unipolar-depressed, and bipolar patients vs control subjects. J Mol Neurosci 2005;26:33-37
64. Lin YM, Chao SC, Chen TM, et al. Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch Gen Psychiatry 2007;64:1015-1024
65. Scheuch K, Lautenschlager M, Grohmann M, et al. Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonin raphe neurons. Biol Psychiatry 2007;62:1288-1294
66. Patel PD, Bochar DA, Turner DL, et al. Regulation of tryptophan hydroxylase-2 gene expression by a bipartite RE-1 silencer of transcription/neuron restrictive silencing factor (REST/NRSF) binding motif. J Biol Chem 2007;282:26717-26724
67. Chen GL, Vallender EJ, Miller GM. Functional characterization of the human TPH2 5¢ regulatory region: untranslated region and polymorphism modulate gene expression in vitro. Hum Genet 2008;122:645-657
68. Zhang X, Gainetdinov RR, Beaulieu J-M, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005;45:11-16
69. McKinney J, Johansson S, Halmoy A, et al. A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention deficit/hyperactivity disorder. Mol Psychiatry 2008;13:365-367
70. McKinney JA, Turel B, Winge I, et al. Functional properties of missense variants of human tryptophan hydroxylase 2. Hum Mutat 2009;30:787-794
71. Harvey M, Shink E, Tremblay M, et al. Support for the involvement of TPH2 gene in affective disorders. Mol Psychiatry 2004;9:980-981
72. Zill P, Baghai TC, Zwanzger P, et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 2004;9:1030-1036
73. Zill P, Buttner A, Eisenmenger W, et al. Single nucleotype polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 2004;56:581-586 (Pubitemid 39336405)
74. Zhou Z, Roy A, Lipsky R, et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 2005;62:1109-1118
75. Ke L, Qi ZY, Ping Y, Ren CY. Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Res 2006;1122:24-26
76. Lopez VA, Detera-Wadleigh S, Cardona I, et al. Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol Psychiatry 2007;61:181-186
77. Lopez de Lara C, Brezo J, Rouleau G, et al. Effect of tryptophan hydroxylase 2 gene variants on suicide risk in major depression. Biol Psychiatry 2007;62:72-80
78. Haghighi F, Bach-Mizrachi H, Huang YY, et al. Genetic architecture of the human tryptophan hydroxilase 2 gene: existence of neural isoforms and relevance for major depression. Mol Psychiatry 2008;13:813-820
79. Cichon S, Winge I, Mattheisen M, et al. Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5¢-region are associated with bipolar affective disorder Hum Mol Genet 2008;17:87-97
80. Canli T, Congdon E, Gutknecht L, et al. Amigdata responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm 2005;112:1479-1485
81. Canli T, Congdon E, Constable RT, Lesch KP. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neutral correlates of affective processing. Biol Psychiatry 2008;79:118-125
82. Herrmann MJ, Huter T, Muller, et al. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex 2007;17:1160-1163
83. Reuter M, Ott U, Vaitl D, Hennig J. Impaired executive control is associated with a variation in the promoter region of the tryptophan hydroxylase 2 gene. J Cogn Neurosci 2007;19:401-408
84. Walitza S, Renner TJ, Dempfle A, et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/ hyperactivity disorder. Mol Psychiatry 2005;10:1126-1132
85. Grigoroiu-Serbanescu M, Diaconu CC, Herms S, et al. Investigation of the tryptophan hydroxylase-2 gene in bipolar I disorder in the Romanian population. Psychiatr Genet 2008;18:240-247
86. Van Den Bogaert A, Sleegers K, De Zutter S, et al. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry 2006;63:1103-1110 (Pubitemid 44498389)
87. Kim Y-K, Lee H-J, Yang JC, et al. A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genet 2009;39:170-175
88. Mossner R, Freitag CM, Gutknecht L, et al. The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder. J Psychopharmacol 2006;20:547-552
89. Delorme R, Durand CM, Betancur C, et al. No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biol Psychiatry 2006;60:202-203
90. Garriock HA, Allen JJ, Delgado P, et al. Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance. Mol Psychiatry 2005;10:976-977
91. Glatt CE, Carlson E, Taylor TR, et al. Response to Zhang, et al (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron 2005;48:704-705
92. Henningsson S, Annerbrink K, Olsson M, et al. Absence of the Arg441His polymorphism in the tryptophan hydroxylase 2 gene in adults with anxiety disorders and depression. Am J Med Genet (Neuropsychiatric Genetics) 2007;177:816-817
93. Van Den Bogaert A, De Zutter S, Heyrman L, et al. Response to Zhang, et al (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron 2005;48:704
94. Cervo L, Canetta A, Calcagno E, et al. Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J Neurosci 2005;25:8165-8172
95. Calcagno E, Canetta A, Guzzetti S, et al. Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity. J Neurochem 2007;103:1111-1120
96. Tzvetkov MV, Brockmoller J, Roots I, Kirchheiner J. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenet Genomics 2008;18:495-506
97. Peters EJ, Slager SL, McGrath PJ, et al. Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 2004;9:879-889
98. Peters EJ, Slager SL, Jenkins GD. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics 2009;19:1-10
99. Tsai SJ, Hong CJ, Liou YJ, et al. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:637-641
100. Young SN. The use of diet and dietary components in the study of factors controlling affect in humans: a review. J Psychiatr Neurosci 1993;18:235-244
101. Miller Miller HL, Delgado PL, Salomon RM, et al. Acute tryptophan depletion: a method of studying antidepressant action. J Clin Psychiatry 1992;53(Suppl):28-35
102. Benkelfat C, Ellenbogen MA, Dean P, et al. Mood-lowering effect of tryptopham depletion. Arch Gen psychiatry 1994;51:687-697
103. Ellenbogen MA, Young SN, Dean P, et al. Mood responses to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacol 1996;15:465-474
104. Leyton M, Young SN, Blier P, et al. The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder. Neuropsychopharmacol 1997;16:294-297
105. Klaassen T, Riedel WJ, van Someren A, et al. Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 1999;46:489-497
106. Neumeister A, Nugent AC, Waldeck T, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004;61:765-773
107. Neumeister A, Praschak-Rieder N, Hesselmann B, et al. Rapid tryptophan depletion in drug-free depressed patients with seasonal affective disorder. Am J Psychiatry 1997;154:1153-1155
108. Moore P, Gillin JC, Bhatti T, et al. Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 1998;55:534-539
109. Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-418
110. Smith KA, Fairburn CG, Cowen PJ. Relapse of depression after rapid depletion of tryptophan. Lancet 1997;349:915-919
111. Spillmann MK, Van der Does AJ, Rankin MA, et al. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology 2001;155:123-127
112. Van der Does AJW. The effect of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 2001;64:107-119
113. Bell C, Abrams J, Nutt D. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 2001;178:399-405
114. Bremner JD, Innis RB, Salomon RM, et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997;54:364-374
115. Aberg-Wistedt A, Hasselmark L, Stain-Malmgren R, et al. Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders. Acta Psychiatr Scand 1998;97:374-380 (Pubitemid 28191915)
116. Fuller RW. Role of serotonin in therapy of depression and related disorders. J Clin Psychiatry 1991;52:52-57
117. Wurtman RJ, Wurtman JJ. Nutritional control of central neurotransmitters. In: Pirk KM, Ploog D, editors, The psychobiology of anorexia nervosa. Springer-Verlag, Berlin; 1984. p. 4-12
118. Fernstrom JD. Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1990;1:508-517
119. Moller SE, Kirk L, Honore P. Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients. J Affect Disord 1980;2:47-59
120. Lam RW, Levitan RD, Tam EM, et al. L-Tryptophan augmentation of light therapy in patients with seasonal affective disorder. Can J Psychiatry 1997;42:303-306
121. Hippius H, Matussek N. Remarks on the therapy of depression with amine precursors. Psychopathology 1986;19:132-135
122. Walinder J, Skott A, Carlsson A, et al. Potentiation of antidepressant action of clomipramine by tryptophan. Arch Gen Psychiatry 1976;33:1384-1389
123. Sandyk R. L-Tryptophan in neuropsychiatric disorders: a review. Int J Neurosci 1992;67:127-144
124. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosomat Med 1999;61:712-728
125. Carroll BJ. Precursor loading strategies. In: Barchas J, Usdin E, editors, Serotonin and behavior. Academic Press, New York; 1973. p. 481-482
126. Young SN, Teff KL. Tryptophan availability, 5HT synthesis and 5HT function. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:373-379
127. Van Praag HM. Management of depression with serotonin precursor. Biol Psychiatry 1981;16:291-310
128. Van Pragg HM, Lemus C, Kahn R. The pitfalls of serotonin precursors as chellengers in hormonal probes of central serotonin activity. Psychopharmacol Bull 1986;22:565-570
129. Heine W, Radke M, Wutzke KD, et al. alpha-Lactalbumin enriched low-protein infant formulas: a comparison to breast milk feeding. Acta Paediatr 1996;85:1024-1028
130. Markus CR, Olivier B, Panhuysen G, et al. The bovine protein alpha-lactalbumin increases the plasma Trp/LNAA, and in vulnerable subjects it raises brain serotonin activity, reduces cortisol and improves mood under stress. Am J Clin Nutr 2000;71:1536-1544
131. Markus CR, Jonkman LM, Lammers J, et al. Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr 2005;81:1026-1033
132. Orosco M, Rouch C, Beslot F, et al. Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behav Brain Res 2004;148:1-10
133. Scrutton H, Carbonnier A, Cowen PJ, Harmer CJ. Effects of alpha-lactalbumin on emotional processing in healthy women. J Psychopharmacol 2007;21:519-524
134. Merens W, Booij L, Markus CR, et al. The effects of a diet enriched with alpha-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls. Br J Nutr 2005;94:415-422
135. Fernstrom JD, Larin F, Wartman RJ. Correlations between brain tryptophan and plasma neutral amino acids levels following food consumption in rats. Life Sci 1973;13:517-524
136. Curzon G. Effects of food intake on brain transmitter amine precursors and amine synthesis. In: Sandler M, Silverstone T, editors, Psychopharmacology and food. Oxford University Press, Oxford; 1985. p. 59-70
137. Wurtmam RJ. Nutrients affecting brain composition and behavior. Integr Psychiatry 1987;5:226-257
138. Wurtman RJ, Wurtman JJ. Carbohydrate craving, obesity and brain serotonin. Appetite 1986;7:99-103
139. Lieberman HR, Wurtman JJ, Chew B. Changes in mood after carbohydrate consumption among obese individuals. Am J Clin Nutr 1986;44:772-778
140. Rosenthal NE, Genhart MJ Caballero B, et al. Psychobiological effects carbohydrate- and protein rich meals in patients with seasonal affective disorder and normal controls. Biol Psychiatry 1989;25:1029-1040
141. Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol 1989;161:1228-1234
142. Steinberg S, Annable L, Young SN. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study. J Psychiatry Neurosci 1994;19:114-119
143. Sayegh R, Schiff I, Wurtman J, et al. The effect of carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995;86:520-528
144. Chen GL, Novak MA, Meyer JS, et al. TPH2 5¢- and 3¢-regulatory polymorphisms are differently associated with HPA axis function and self-injurious behavior in rhesus monkeys. Genes Brain Behav 2010;9:335-347
145. Popova NK, Naumenko VS, Cybko AS, Bazovkina DV. Receptor-genes cross-talk: effect of chronic 5-HT1A agonist 8-hydroxy-2-(di-N-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior. Neurosci 2010;169:229-235
146. Pey AL, Desviat LR, Gamez A, et al. Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH. Hum Mutat 2003;21:370-378
147. Waters PJ. How PAH gene mutations cause hyperphenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 2003;21:357-369
148. Grohmann M, Hammer P, Walther M, et al. Alternative splicing and extensive RNA editing of human TPH2 transcripts. PLos ONE 2010;5:e8956
149. Matthes S, Mosienko V, Bashammakh S, et al. Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology 2010;85:95-109